enGene Ownership | Who Owns enGene?


OverviewForecastFinancialsChart

enGene Ownership Summary


enGene is owned by 79.23% institutional investors, 13.63% insiders, and 7.15% retail investors. Fcpm iii services b.v. is the largest institutional shareholder, holding 18.88% of ENGN shares.

ENGN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockenGene79.23%13.63%7.15%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fcpm iii services b.v.9.63M18.88%$35.06M
Vr adviser5.05M9.89%$18.37M
Kynam capital management, lp4.99M9.79%$18.18M
Deep track capital, lp4.56M8.93%$16.59M
Blue owl capital lp3.73M7.31%$13.57M
Cormorant asset management, lp2.32M4.55%$8.46M
Point72 asset management1.21M2.37%$4.40M
Adage capital partners gp1.00M1.96%$3.64M
Orbimed advisors677.98K1.33%$2.47M
Omega fund management526.36K1.03%$1.92M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fcpm iii services b.v.9.63M9.50%$35.06M
Blue owl capital lp3.73M4.38%$13.57M
Kynam capital management, lp4.99M1.96%$18.18M
Vr adviser5.05M1.38%$18.37M
Omega fund management526.36K1.24%$1.92M
Cormorant asset management, lp2.32M0.63%$8.46M
Deep track capital, lp4.56M0.53%$16.59M
Sphera funds management504.41K0.43%$1.84M
Vestal point capital, lp370.00K0.07%$1.35M
Orbimed advisors677.98K0.06%$2.47M

Top Buyers

HolderShares% AssetsChange
Blue owl capital lp3.73M4.38%448.73K
Affinity asset advisors77.00K0.04%77.00K
Paloma partners management10.32K0.01%10.32K
Cresset asset management10.00K0.00%10.00K
Adar1 capital management27.79K0.02%3.99K

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp1.00M0.01%-571.64K
Orbimed advisors677.98K0.06%-213.64K
Mai capital management2.92K0.00%-75.14K
Point72 asset management1.21M0.01%-32.89K
Sphera funds management504.41K0.43%-23.96K

New Positions

HolderShares% AssetsChangeValue
Affinity asset advisors77.00K0.04%77.00K$280.28K
Paloma partners management10.32K0.01%10.32K$37.56K
Cresset asset management10.00K0.00%10.00K$36.40K
Raymond james financial2.07K-2.07K$7.53K
Nbc securities380.000.00%380.00$1.00

Sold Out

HolderChange
Ubs group-1.20K
Sectoral asset management-11.70K
Two sigma investments, lp-15.83K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20253719.35%40,420,485-1.27%791.23%1344.44%912.50%
Mar 31, 202531-8.82%40,941,351-0.88%801.22%9-59.09%814.29%
Dec 31, 20243413.33%41,304,52820.44%811.34%2237.50%775.00%
Sep 30, 202430-34,293,3915.17%771.42%1614.29%4-33.33%
Jun 30, 202430-3.23%32,608,6013.00%731.15%14-41.67%6100.00%

Recent Insider Transactions


DateNameRoleActivityValue
Oct 30, 2024Forbion Growth Opportunities Fund I Cooperatief U.A.-Buy$5.00M
Oct 07, 2024Forbion Growth Opportunities Fund I Cooperatief U.A.-Buy$77.53K
Oct 04, 2024Forbion Growth Opportunities Fund I Cooperatief U.A.-Buy$39.24K
Oct 03, 2024Forbion Growth Opportunities Fund I Cooperatief U.A.-Buy$37.40K
Oct 08, 2024Forbion Growth Opportunities Fund I Cooperatief U.A.-Buy$5.28K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q47-
2024 Q34-

ENGN Ownership FAQ


Who Owns enGene?

enGene shareholders are primarily institutional investors at 79.23%, followed by 13.63% insiders and 7.14% retail investors. The average institutional ownership in enGene's industry, Biotech Stocks , is 306.59%, which enGene falls below.

Who owns the most shares of enGene?

enGene’s largest shareholders are Fcpm iii services b.v. (9.63M shares, 18.88%), Vr adviser (5.05M shares, 9.89%), and Kynam capital management, lp (4.99M shares, 9.79%). Together, they hold 38.56% of enGene’s total shares outstanding.

Does Blackrock own enGene?

BlackRock is not among the top 10 institutional shareholders of enGene.

Who is enGene’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is enGene’s biggest shareholder by percentage of total assets invested, with 9.50% of its assets in 9.63M enGene shares, valued at 35.06M$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools